AU Patent

AU2024307335A1 — Pharmaceutical composition containing uracil derivative

Assigned to Shionogi and Co Ltd · Expires 2026-04-16 · 0y expired

What this patent protects

The present invention provides a pharmaceutical composition containing a compound that exhibits coronavirus growth–inhibiting activity. Provided is a pharmaceutical composition containing a compound represented by formula (I-1) or a pharmaceutically acceptable salt thereof.

USPTO Abstract

The present invention provides a pharmaceutical composition containing a compound that exhibits coronavirus growth–inhibiting activity. Provided is a pharmaceutical composition containing a compound represented by formula (I-1) or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024307335A1
Jurisdiction
AU
Classification
—
Expires
2026-04-16
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.